Date: 2025/05/13 - 23:32
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers.
Date: 2025/05/12 - 22:00
A 3-month time-restricted eating (TRE) protocol resulted in up to one year of sustained weight loss in people with overweight or obesity. Adhering to an 8-hour window of eating led to greater weight loss than eating throughout the day, whether early or late.
Date: 2025/05/09 - 22:00
Attorneys general in 19 states and Washington, D.C., filed a lawsuit challenging the Trump administration's plans to significantly reduce staffing at the Department of Health and Human Services (HHS), which could disrupt public health services, such as safeguarding food and medication supplies.
Date: 2025/05/07 - 00:31
Researchers have identified a new set of urine-based biomarkers that can accurately detect both the presence and severity of prostate cancer as an alternative to a PSA test, aiding early diagnosis.
Date: 2025/05/05 - 23:00
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in nearly two-thirds of participants, twice the rate seen with placebo.